Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nuwellis Inc NUWE

Healthcare Medical Devices
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms... see more

Recent & Breaking News (NDAQ:NUWE)

New Publication Highlights Transient Increases in Creatinine or Tubular Injury Markers in Heart Failure Patients Should Not Dissuade Use of Ultrafiltration

GlobeNewswire August 8, 2019

CHF Solutions, Inc. Announces 53 Percent Increase in Revenues for Second Quarter 2019 Over Previous Year and 38 Percent Increase from Q1 2019

GlobeNewswire August 6, 2019

CHF Solutions, Inc. To Announce Second Quarter 2019 Financial Results and Corporate Update on August 6, 2019

GlobeNewswire July 30, 2019

Texas Health Resources Launches Ultrafiltration Therapy Using CHF Solutions' Aquadex FlexFlow® System

GlobeNewswire July 16, 2019

CHF Solutions To Exhibit At the American Association of Heart Failure Nurses 15th Annual Meeting

GlobeNewswire June 25, 2019

CHF Solutions Sponsored AATS Session on Post-Cardiac Surgery, Highlighting Benefits of Using the Aquadex FlexFlow® System Following Cardiac Surgery

GlobeNewswire June 13, 2019

CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire May 29, 2019

CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Beebe Healthcare

GlobeNewswire May 15, 2019

CHF Solutions, Inc. Announces 17 Percent Increase in Revenues for First Quarter 2019 Over Previous Year and Provides Company Update

GlobeNewswire May 7, 2019

CHF Solutions Welcomes Industry Veteran Nestor Jaramillo as Chief Commercial Officer

GlobeNewswire May 6, 2019

CHF Solutions, Inc. To Announce First Quarter 2019 Financial Results on May 7, 2019

GlobeNewswire April 30, 2019

CHF Solutions to Sponsor CT Theatre Session, "Personalized Medicine: Improving Clinical Outcomes with Novel Fluid Management Strategies" Moderated by Renowned Cardiothoracic Surgeon Daniel Beckles, M.D., Ph.D., at the 2019 AATS Annual Meeting

GlobeNewswire April 23, 2019

CHF Solutions Announces Launch of Ultrafiltration Program at Oklahoma Heart Institute

GlobeNewswire April 9, 2019

CHF Solutions Submits Patent Application for Pediatric Use of Aquadex FlexFlow® System

GlobeNewswire April 3, 2019

CHF Solutions to Exhibit at The International Society for Heart and Lung Transplantation 2019 Annual Meeting and Scientific Sessions

GlobeNewswire March 28, 2019

Newly Published Article Demonstrates Ultrafiltration with CHF Solutions’ Aquadex FlexFlow® System Reduces Hospital Costs by Lowering 90-Day Re-admissions and Durations of Stay in Heart Failure Patients

GlobeNewswire March 26, 2019

CHF Solutions, Inc. Announces Closing of $12.42 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

GlobeNewswire March 12, 2019

CHF Solutions, Inc. Announces Pricing of $10.8 Million Underwritten Public Offering

GlobeNewswire March 8, 2019

CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire March 1, 2019

CHF Solutions, Inc. Announces 80% Revenue Growth for its Fourth Quarter and Provides Company Update

GlobeNewswire February 20, 2019